Savaria Corp (SIS.TO) Buy, Sell or Hold

Savaria Corp (SIS.TO)

29.20

+0.45 (1.57%)

as of Sep 18, 2026, 8:00:00 pm Market Open.

308 watching

BUY

Quite interesting. Like other healthcare stocks, SIS has a tailwind in demographics that'll continue to build their business. Often in Canada, investors focus on a few businesses, so this stock had a big move up, then went through a sideways consolidation period. Recently, they made a big purchase which didn't surprise him--he's now looking at it. The current valuation is quite compelling. When this Swedish deal is completed, it could drive the stock up.

BUY

Allan Tong’s Discover Picks Savaria is a smaller-cap stock worth $890 million. Frankly, SIS stock hadn’t been doing much in recent years apart from paying a consistent dividend (currently 2.86%) and growing modestly by acquisition. Then, last week Savaria offered to buy Sweden’s Handicare for $521.1 million. Like Savaria, Handicare makes lifts in the homes of seniors. For the fiscal year ending December 31, 2020, Handicare reported sales of 205 million euros ($317 million). Read 3 Dependable Canadian Stocks to Buy in 2021/a> for our full analysis.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The Handicare acquisition is very big and will increase revenues by 50%. 5i likes the deal and believes there will be additional synergie over time. The deal is set to increase geographic reach and customer base. The financing may cause short term volatility but EBITDA was better than expected and sales were just below estimates. Unlock Premium - Try 5i Free

TOP PICK

Great company. Demand for their product. so people can stay in their homes. Beat expectations. EBITDA margin of 19%, its highest in years. Controlling expenses really well. On verge of creating more sustainable profitability, as well as increasing optionality on the M&A front. Management is doing a spectacular job. Yield is 3.4%. (Analysts’ price target is $17.47)

TOP PICK

For seniors, there are some legal ramifications post-pandemic. If people want to stay home instead of go into a long term care facility, their mobility products for seniors will do well. He likes the sustainability and growth potential of the dividend. Yield 3.32% (Analysts’ price target is $14.91)

COMMENT

They suffered disappointing numbers last year and have been hit by the virus like the wider markets, but SIS has done well over five years. Aging demographics are on their side, but it has underperformed recently. You must have a long-term view on this.

DON'T BUY

There is all this growth potential in the stair lifts but a big chunk of their business is car lifts, which are a big luxury and which is in decline. He is slightly short the stock. He doesn't see a huge upside.

COMMENT

A pretty good growth story over the last couple years. They have grown well through acquisition. Not seeing organic growth, and it’s not cheap.

COMMENT

It’s in a nice uptrend and is coming back to consolidation levels. He would say the exit point is around $13.25. Technically, everything looks good.

PAST TOP PICK

(A Top Pick Nov 18/18, Down 9%) Overall it has been down because they did acquisitions and margins are staring to slip. The last quarter looks good. He thinks it will get back to buying companies. It is going to have a rising tide in terms of demand.

PAST TOP PICK

(A Top Pick Mar 29/19, Down 8%) A small cap that specializes in wheelchair elevators in homes and vehicles. None of us are getting younger, and demand will go up. A buying opportunity. It's a long term play at a 3 to 5 year view.

WATCH

He sold a lot of this in the high-teens when the valuation got ahead of itself. He wants to buy back, but first needs to see organic growth in stair lifts, for example. SIS also needs to better integrate acquisitions. But he likes the managers and this sector. Insiders just bought more share and increased the dividend.

DON'T BUY

Doesn't like the chart now, after falling from $18. It's breaking below support.

WATCH

A health care product provider. They had been on an acquisition spree but margins were slipping and they have been trying to improve them. He thinks they will get growth back to the name but he would wait for their earnings report.

DON'T BUY

Feb.15-June 2 is seasonality, but we see lower lows and lower highs. If this doesn't hold at $12, this will fall lower. Wait till momentum improves.

Showing 46 to 60 of 127 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Mike Philbrick

ReSolve Asset Management

Martin Cobb, ASIP

Lorne Steinberg Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Savaria Corp (SIS.TO)